<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">34687585</PMID><DateRevised><Year>2021</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-0528</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2021</Year><Month>Oct</Month><Day>23</Day></PubDate></JournalIssue><Title>BJOG : an international journal of obstetrics and gynaecology</Title><ISOAbbreviation>BJOG</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 infection among hospitalised pregnant women and impact of different viral strains on COVID-19 severity in Italy: a national prospective population-based cohort study.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1111/1471-0528.16980</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The primary aim of this article was to describe SARS-CoV-2 infection among pregnant women during the wild-type and Alpha-variant periods in Italy. The secondary aim was to compare the impact of the virus variants on the severity of maternal and perinatal outcomes.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">National population-based prospective cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">A total of 315 Italian maternity hospitals.</AbstractText><AbstractText Label="SAMPLE" NlmCategory="METHODS">A cohort of 3306 women with SARS-CoV-2 infection confirmed within 7 days of hospital admission.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Cases were prospectively reported by trained clinicians for each participating maternity unit. Data were described by univariate and multivariate analyses.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">COVID-19 pneumonia, ventilatory support, intensive care unit (ICU) admission, mode of delivery, preterm birth, stillbirth, and maternal and neonatal mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We found that 64.3% of the cohort was asymptomatic, 12.8% developed COVID-19 pneumonia and 3.3% required ventilatory support and/or ICU admission. Maternal age of 30-34 years (OR 1.43, 95% CI 1.09-1.87) and ≥35 years (OR 1.62, 95% CI 1.23-2.13), citizenship of countries with high migration pressure (OR 1.75, 95% CI 1.36-2.25), previous comorbidities (OR 1.49, 95% CI 1.13-1.98) and obesity (OR 1.72, 95% CI 1.29-2.27) were all associated with a higher occurrence of pneumonia. The preterm birth rate was 11.1%. In comparison with the pre-pandemic period, stillbirths and maternal and neonatal deaths remained stable. The need for ventilatory support and/or ICU admission among women with pneumonia increased during the Alpha-variant period compared with the wild-type period (OR 3.24, 95% CI 1.99-5.28).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our results are consistent with a low risk of severe COVID-19 disease among pregnant women and with rare adverse perinatal outcomes. During the Alpha-variant period there was a significant increase of severe COVID-19 illness. Further research is needed to describe the impact of different SARS-CoV-2 viral strains on maternal and perinatal outcomes.</AbstractText><CopyrightInformation>© 2021 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Donati</LastName><ForeName>S</ForeName><Initials>S</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-4607-2072</Identifier><AffiliationInfo><Affiliation>National Centre for Disease Prevention and Health Promotion, Istituto Superiore di Sanità - Italian National Institute of Health, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corsi</LastName><ForeName>E</ForeName><Initials>E</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-1337-2666</Identifier><AffiliationInfo><Affiliation>National Centre for Disease Prevention and Health Promotion, Istituto Superiore di Sanità - Italian National Institute of Health, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maraschini</LastName><ForeName>A</ForeName><Initials>A</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-4754-5385</Identifier><AffiliationInfo><Affiliation>Servizio tecnico scientifico di statistica, Istituto Superiore di Sanità - Italian National Institute of Health, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salvatore</LastName><ForeName>M A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>National Centre for Disease Prevention and Health Promotion, Istituto Superiore di Sanità - Italian National Institute of Health, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>ItOSS-COVID-19 Working Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BJOG</MedlineTA><NlmUniqueID>100935741</NlmUniqueID><ISSNLinking>1470-0328</ISSNLinking></MedlineJournalInfo><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 pneumonia</Keyword><Keyword MajorTopicYN="N">Cohort studies</Keyword><Keyword MajorTopicYN="N">Italy</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">pregnancy</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Arena</LastName><ForeName>Maria Grazia</ForeName><Initials>MG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boldrini</LastName><ForeName>Rosaria</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brunelli</LastName><ForeName>Roberto</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cagnacci</LastName><ForeName>Angelo</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Casucci</LastName><ForeName>Paola</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cetin</LastName><ForeName>Irene</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cobellis</LastName><ForeName>Luigi</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dardanoni</LastName><ForeName>Gabriella</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Ambrosi</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Del Manso</LastName><ForeName>Martina</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>D'Eusanio</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Driul</LastName><ForeName>Lorenza</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Epicoco</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fabiani</LastName><ForeName>Massimo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Franchi</LastName><ForeName>Massimo Piergiuseppe</ForeName><Initials>MP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leo</LastName><ForeName>Livio</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Liberati</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Locci</LastName><ForeName>Mariavittoria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lo Re</LastName><ForeName>Antonino</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martini</LastName><ForeName>Claudio</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maso</LastName><ForeName>Gianpaolo</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mecacci</LastName><ForeName>Federico</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meloni</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mignuoli</LastName><ForeName>Anna Domenica</ForeName><Initials>AD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mondo</LastName><ForeName>Luisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perrone</LastName><ForeName>Enrica</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Porcino</LastName><ForeName>Lucia</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ramenghi</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Savasi</LastName><ForeName>Valeria</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schettini</LastName><ForeName>Sergio Crescenzo Antonio</ForeName><Initials>SCA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scorpio</LastName><ForeName>Gabriella</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Simeone</LastName><ForeName>Daniela</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Simeone</LastName><ForeName>Serena</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Steinkasserer</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taddei</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tateo</LastName><ForeName>Saverio</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Trojano</LastName><ForeName>Vito</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tronci</LastName><ForeName>Caterina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vimercati</LastName><ForeName>Antonella</ForeName><Initials>A</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>08</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>23</Day><Hour>17</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34687585</ArticleId><ArticleId IdType="doi">10.1111/1471-0528.16980</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Funk T, Pharris A, Spiteri G, Bundle N, Melidou A, Carr M, et al. Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries. Euro Surveill 2021;26:2100348. https://doi.org/10.2807/1560-7917.ES.2021.26.16.2100348</Citation></Reference><Reference><Citation>Istituto Superiore di Sanità, Fondazione Bruno Kessler e Ministero della Salute. Prevalenza delle varianti VOC (Variant Of Concern) in Italia: lineage B.1.1.7, P.1, P.2, lineage B.1.351, lineage B.1.525 (Indagine del 18/2/2021) [Presence of Variant Of concern in Italy: lineage B.1.1.7, P.1, P.2, lineage B.1.351, lineage B.1.525 Survey of 18/02/2021]. [Italian] [https://www.epicentro.iss.it/coronavirus/pdf/sars-cov-2-monitoraggio-varianti-indagini-rapide-18-marzo-2021.pdf]. Accessed 29 September 2021.</Citation></Reference><Reference><Citation>Istituto Superiore di Sanità, Fondazione Bruno Kessler e Ministero della Salute. Prevalenza delle varianti VOC (Variant Of Concern) in Italia: lineage B.1.1.7, P.1, P.2, lineage B.1.351, lineage B.1.525 (Indagine del 18/3/2021) [Presence of Variant Of concern in Italy: lineage B.1.1.7, P.1, P.2, lineage B.1.351, lineage B.1.525 Survey of 18/03/2021]. [Italian] [https://www.epicentro.iss.it/coronavirus/pdf/sars-cov-2-monitoraggio-varianti-indagini-rapide-18-marzo-2021.pdf]. Accessed 29 September 2021.</Citation></Reference><Reference><Citation>Istituto Superiore di Sanità, Fondazione Bruno Kessler e Ministero della Salute. Prevalenza delle varianti VOC (Variant Of Concern) in Italia: lineage B.1.1.7, P.1, P.2, lineage B.1.351, lineage B.1.525 (Indagine del 22/6/2021) [Presence of Variant Of concern in Italy: lineage B.1.1.7, P.1, P.2, lineage B.1.351, lineage B.1.525 Survey of 22/06/2021]. [Italian] [https://www.epicentro.iss.it/coronavirus/pdf/sars-cov-2-monitoraggio-varianti-indagini-rapide-18-marzo-2021.pdf]. Accessed 29 September 2021.</Citation></Reference><Reference><Citation>Kadiwar S, Smith JJ, Ledot S, Johnson M, Bianchi P, Singh N, et al. Were pregnant women more affected by COVID-19 in the second wave of the pandemic? Lancet 2021;397:1539-40. https://doi.org/10.1016/S0140-6736(21)00716-9</Citation></Reference><Reference><Citation>Vousden N, Ramakrishnan R, Bunch K, Morris E, Simpson N, Gale C, et al. Impact of SARS-CoV-2 variant on the severity of maternal infection and perinatal outcomes: Data from the UK Obstetric Surveillance System national cohort. Preprint. medRxiv 2021;2021.07.22.21261000. Published 2021 Jul 22. https://doi.org/10.1101/2021.07.22.21261000</Citation></Reference><Reference><Citation>Maraschini A, Corsi E, Salvatore MA, Donati S; ItOSS COVID-19 Working Group. Coronavirus and birth in Italy: results of a national population-based cohort study. Ann Ist Super Sanita 2020;56:378-89. https://doi.org/10.4415/ANN_20_03_17</Citation></Reference><Reference><Citation>Corsi E, Maraschini A, Perrone E, Salvatore MA, D'aloja P, Donati S. La preparedness dell'Italian obstetric surveillance system in occasione della pandemia da SARS-CoV-2: aspetti metodologici di uno studio di popolazione [The preparedness of the Italian obstetric surveillance system in the response to the emergency of the SARS-CoV-2 pandemic: methodological aspects of a population-based study]. Epidemiol Prev 2020;44:81-87. https://doi.org/10.19191/EP20.5-6.S2.089</Citation></Reference><Reference><Citation>Donati S, Corsi E, Salvatore MA, Maraschini A, Bonassisa S, Casucci P, et al. Childbirth care among SARS-CoV-2 positive women in Italy. Int J Environ Res Public Health 2021;18:4244.</Citation></Reference><Reference><Citation>Donati S, Maraschini A, Dell'Oro S, Lega I, D'Aloja P; Regional Maternal Mortality Working Group. The way to move beyond the numbers: the lesson learnt from the Italian Obstetric Surveillance System. Ann Ist Super Sanita 2019;55:363-70. https://doi.org/10.4415/ANN_19_04_10</Citation></Reference><Reference><Citation>Maraschini A, Lega I, D'Aloja P, Buoncristiano M, Dell'Oro S, Donati S, et al. Women undergoing peripartum hysterectomy due to obstetric hemorrhage: a prospective population-based study. Acta Obstet Gynecol Scand 2020;99:274-82. https://doi.org/10.1111/aogs.13727</Citation></Reference><Reference><Citation>Ornaghi S, Maraschini A, Donati S; Regional Obstetric Surveillance System Working Group. Characteristics and outcomes of pregnant women with placenta accreta spectrum in Italy: a prospective population-based cohort study. PLoS One 2021;16:e0252654. https://doi.org/10.1371/journal.pone.0252654</Citation></Reference><Reference><Citation>Donati S, Fano V, Maraschini A; Regional Obstetric Surveillance System Working Group. Uterine rupture: results from a prospective population-based study in Italy. Eur J Obstet Gynecol Reprod Biol 2021;264:70-5. https://doi.org/10.1016/j.ejogrb.2021.07.001</Citation></Reference><Reference><Citation>Knight M; INOSS. The International Network of Obstetric Survey Systems (INOSS): benefits of multi-country studies of severe and uncommon maternal morbidities. Acta Obstet Gynecol Scand 2014;93:127-31. https://doi.org/10.1111/aogs.12316</Citation></Reference><Reference><Citation>Istituto Nazionale di Statistica (ISTAT). La presenza straniera in Italia: caratteristiche socio-demografiche - Permessi di soggiorno al 1° gennaio degli anni 2001, 2002, 2003 [The foreign population living in Italy: socio-demographic characteristics - years 2001, 2002, 2003]. [Italian] [http://www.cestim.it/sezioni/dati_statistici/italia/Istat/2004-06%20permessi%20soggiorno%20Italia%202001%202003.pdf]. Accessed 4 August 2021.</Citation></Reference><Reference><Citation>Directorate-general of digitalization, of health informative system and of statistics, Italian Ministry of Health. Certificato di assistenza al parto (CeDAP). Analisi dell’evento nascita - 2019 [Birth Registry - Year 2019]. [Italian] [http://www.salute.gov.it/imgs/C_17_pubblicazioni_3076_allegato.pdf]. Accessed 4 August 2021.</Citation></Reference><Reference><Citation>Istituto Nazionale di Statistica (ISTAT). La dinamica demografica durante la pandemia COVID-19 - Anno 2020 [The demographic dynamic during the COVID-19 pandemic - Year 2020]. [Italian] [https://www.istat.it/it/files/2021/03/REPORT-IMPATTO-COVIDDEMOGRAFIA_2020.pdf]. Accessed 4 August 2021.</Citation></Reference><Reference><Citation>White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011;30:377-99. https://doi.org/10.1002/sim.4067</Citation></Reference><Reference><Citation>Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York, NY: Wiley; 1987.</Citation></Reference><Reference><Citation>Riccardo F, Ajelli M, Andrianou XD, Bella A, Del Manso M, Fabiani M, et al. Epidemiological characteristics of COVID-19 cases and estimates of the reproductive numbers 1 month into the epidemic, Italy, 28 January to 31 March 2020. Euro Surveill 2020;25:2000790. https://doi.org/10.2807/1560-7917.ES.2020.25.49.2000790</Citation></Reference><Reference><Citation>EpiCentro - Epidemiology for Public Health - Istituto Superiore di Sanità (ISS) - Italian National Institute of Health. The Italian Obstetric Surveillance System (ItOSS). Maternal Mortality Surveillance [https://www.epicentro.iss.it/en/itoss/maternal-mortality-surveillance]. Accessed 4 August 2021.</Citation></Reference><Reference><Citation>Directorate-General of Digitalization, of Health Informative System and of Statistics, Italian Ministry of Health. Birth Registry - Year 2019. Data provided by Rosaria Boldrini.</Citation></Reference><Reference><Citation>Knight M, Bunch K, Vousden N, Morris E, Simpson N, Gale C, et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ 2020;369:m2107. https://doi.org/10.1136/bmj.m2107</Citation></Reference><Reference><Citation>Vousden N, Bunch K, Morris E, Simpson N, Gale C, O'Brien P, et al. The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: a national cohort study using the UK Obstetric Surveillance System (UKOSS). PLoS One 2021;16:e0251123. https://doi.org/10.1371/journal.pone.0251123</Citation></Reference><Reference><Citation>Engjom H, Aabakke AJM, Klungsøyr K, Svanvik T, Äyräs O, Jonasdottir E, et al. COVID-19 in pregnancy-characteristics and outcomes of pregnant women admitted to hospital because of SARS-CoV-2 infection in the Nordic countries. Acta Obstet Gynecol Scand 2021;100:1611-9. https://doi.org/10.1111/aogs.14160</Citation></Reference><Reference><Citation>Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Tong VT, et al. Update: Characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-October 3, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1641-7. https://doi.org/10.15585/mmwr.mm6944e3</Citation></Reference><Reference><Citation>Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ 2020;370:m3320. https://doi.org/10.1136/bmj.m3320</Citation></Reference><Reference><Citation>Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A, et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID Multinational Cohort Study. JAMA Pediatr 2021;175:817-26. https://doi.org/10.1001/jamapediatrics.2021.1050</Citation></Reference><Reference><Citation>Khalil A, Kalafat E, Benlioglu C, O'Brien P, Morris E, Draycott T, et al. SARS-CoV-2 infection in pregnancy: a systematic review and meta-analysis of clinical features and pregnancy outcomes. EClinicalMedicine 2020;25:100446. https://doi.org/10.1016/j.eclinm.2020.100446</Citation></Reference><Reference><Citation>Ciapponi A, Bardach A, Comandé D, Berrueta M, Argento FJ, Rodriguez Cairoli F, et al. COVID-19 and pregnancy: An umbrella review of clinical presentation, vertical transmission, and maternal and perinatal outcomes. PLoS One 2021;16:e0253974. https://doi.org/10.1371/journal.pone.0253974</Citation></Reference><Reference><Citation>EpiCentro - Epidemiology for Public Health - Istituto Superiore di Sanità (ISS) - Italian National Institute of Health. COVID-19: Pregnancy, Childbirth and Breastfeeding [https://www.epicentro.iss.it/en/coronavirus/sars-cov-2-pregnancy-childbirth-breastfeeding]. Accessed 4 August 2021.</Citation></Reference><Reference><Citation>EpiCentro - Epidemiology for Public Health - Istituto Superiore di Sanità (ISS) - Italian National Institute of Health. The Italian Obstetric Surveillance System (ItOSS). Interim Guidance “The use of COVID-19 vaccines in pregnant and lactating patients” - Updated on January 31st 2021 [https://www.epicentro.iss.it/vaccini/pdf/ItOSS%20Vaccination%20against%20COVID-19%20in%20pregnancy_feb.09.2021.pdf]. Accessed 4 August 2021.</Citation></Reference><Reference><Citation>EpiCentro - Epidemiology for Public Health - Istituto Superiore di Sanità (ISS) - Italian National Institute of Health. The Italian Obstetric Surveillance System (ItOSS). Interim Guidance “The use of COVID-19 Vaccines in Pregnant and Lactating Patients” - Updated on September 22 2021 [https://www.epicentro.iss.it/vaccini/pdf/Aggiornamento%20indicazioni%20ISS%20su%20vaccino%20in%20grav_%20e%20allatt_2021.pdf]. Accessed 29 September 2021.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>